Kymera Therapeutics

Kymera Therapeutics Appoints Industry Veteran Mark E. Nuttall, Ph.D., as Chief Business Officer

Don W. Nicholson, Ph.D. joins Board of Directors Cambridge, Mass. (February 6, 2018) –  Kymera Therapeutics LLC, a biotechnology company pioneering targeted-protein degradation as a transformative new approach to creating breakthrough medicines for patients, today announced the appointment of